Need help? Our team of experienced experts is here for you with full support.
AKA-402
AktiAmino™ Fmoc-L-Tyr(tBu)-OH
Cat. No.
AKA-402
CAS No.
71989-38-3
MF
C28H29NO5
MW
459.53
AktiAmino™ Fmoc-L-Tyr(tBu)-OH is a doubly protected L-tyrosine derivative. Its α-amino group is protected by Fmoc, its side-chain phenolic hydroxyl group is protected as a tert-butyl ether, and its α-carboxyl group remains free. It is used to incorporate L-tyrosine residues during solid-phase peptide synthesis.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Data
Description
Storage and Shipping
References
Product Name
AktiAmino™ Fmoc-L-Tyr(tBu)-OH
CAS No.
71989-38-3
MF
C28H29NO5
MW
459.53
Specification
99%
Documents
Certificate of Analysis (COA), Specification sheet, Safety Data Sheet (SDS/MSDS) etc.
Description
AktiAmino™ Fmoc-L-Tyr(tBu)-OH is a doubly protected L-tyrosine derivative. Its α-amino group is protected by Fmoc, its side-chain phenolic hydroxyl group is protected as a tert-butyl ether, and its α-carboxyl group remains free. It is used to incorporate L-tyrosine residues during solid-phase peptide synthesis. Packing: 1kg/bag,25kg/drum or as request Availability: In stock
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1].Adamson JG, Blaskovich MA, Groenevelt H, Lajoie GA. Simple and convenient synthesis of tert-butyl ethers of Fmoc-serine, Fmoc-threonine, and Fmoc-tyrosine. J Org Chem. 1991;56(10):3447–9. doi:10.1021/jo00010a050.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.